Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Jean-Francois Jasmin
Introduction
Jean-Francois Jasmin is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Jasmin's work focuses on targeted therapies that aim to improve patient outcomes.
Latest Patents
One of his latest patents involves the development of polypeptides for the treatment of cancer. This patent outlines methods of treating cancer using co-activator of activator protein-1 and estrogen receptor (CAPER)-based polypeptides. The methods described in this patent specifically target cancerous cells while minimizing adverse effects on non-cancerous cells. Another significant patent by Jasmin relates to caveolin-1 related methods for treating glioblastoma with temozolomide. This invention provides a method for treating patients afflicted with glioblastoma multiforme by administering a therapeutically effective regimen of temozolomide. It also includes a method for determining whether a patient’s glioblastoma multiforme cells are caveolin-1-positive, which indicates a likelihood of therapeutic progression in response to treatment.
Career Highlights
Throughout his career, Jean-Francois Jasmin has worked with esteemed institutions such as Saint Joseph's University and Thomas Jefferson University. His research has contributed to advancements in cancer therapies, showcasing his commitment to improving healthcare outcomes.
Collaborations
Jasmin has collaborated with notable colleagues, including Shannon Chilewski and Isabelle Mercier. These partnerships have further enhanced his research efforts and contributed to the development of innovative treatment methods.
Conclusion
Jean-Francois Jasmin's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents reflect a dedication to advancing therapeutic options for patients, highlighting the importance of targeted therapies in modern medicine.